Winner
The Big Conversation
Summary of work
Boehringer Ingelheim (BI) is looking to establish itself as an oncology brand in the UK market. The agency developed the Big Conversation meeting series as a platform for BI to build a presence in the oncology space without the use of a field force.
The Big Conversation is a high-quality, national meeting programme that marries creative digital innovation, medical education and highly scientific content. An iPad-based, fully live interactive case study format encouraging communication and discussion helped deliver a truly successful national and regional meeting programme.
The meeting series attracted over 300 professionals from across the UK and showcased BI as a company dedicated to delivering quality medical education via a pioneering digital medium.
Judges’ comments
They’ve really thought about how to use the technology and how to link it together with the programme. Attendees will have heard something they haven’t heard before and it will lead to a change in practice. Very interesting strategy brought to the conversation, not many companies would have done that.
Testimonials and Judges’ comments
Senior product manager: As a new entrant into the UK oncology community we really had to make our mark with this meeting series. The agency developed a high quality programme that really delivered on our corporate vision. The communications platform they put into place met each and every objective we set for this programme – in all, an innovative, creative and impactful programme which Boehringer Ingelheim are proud to have sponsored.
